In-depth longitudinal sequences from a single subject, together with clinical and antibody neutralization data.
Hua-Xin Liao, Rebecca Lynch, Tongqing Zhou, Feng Gao, S. Munir Alam, Scott D. Boyd, Andrew Z. Fire, Krishna M. Roskin, Chaim A. Schramm, Zhenhai Zhang, Jiang Zhu, Lawrence Shapiro, NISC Comparative Sequencing Program, James C. Mullikin, Gnana Gnanakaran, Peter Hraber, Kevin Weihe, Garnett Kelsoe, Guang Yang, Shi-Mao Xia, David C. Montefiori, Robert Parks, Krissey E. Lloyd, Richard M. Scearce, Kelly D. Soderberg, Myron Cohen, Gift Kaminga, Mark K Louder, Lillan M. Tran, Yue Chen, Fangping Cai, Sheri Chen, Stephanie Moquin, Xiulian Du, Gordon M. Joyce, Sanjay Srivatsan, Baoshan Zhang, Anqi Zheng, George M. Shaw, Beatrice H. Hahn, Thomas B. Kepler, Bette T.M. Korber, Peter D. Kwong, John R. Mascola, Barton F. Haynes.
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 497(7446):469-76, 2013. doi:10.1038/nature12053 PMID 23552890.
This study was supported by the National Institutes of Allergy and Infectious Diseases and by intramural NIH support for the NIAID Vaccine Research Center, by grants from the NIH, NIAID, AI067854 (The Center for HIV/AIDS Vaccine Immunology) and AI100645 (The Center for Vaccine Immunology-Immunogen Discovery).